Outline.

Slides:



Advertisements
Similar presentations
Delphine Sculier, MD,MPH Stop TB Department World Health Organisation Geneva, Switzerland Update on the revision of ART guidelines for TB patients.
Advertisements

SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
Hcv infection and management in advanced liver disease
Interventional Oncology Michael Kotton MD October 27, 2012.
The Progression of Liver Fibrosis is Associated with the Severity of the HIV Disease in HIV-HCV Co-infected Female Patients Mohammad K. Mohammad 1, Babu.
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients Deirdre Sawinski MD, Kimberly A.
Factors Associated With Survival of HIV/HBV Co-infected Patients in Uganda By Ruth Atuhaire Makerere University Business School,
Module 3: HCV prevalence and course of HCV infection.
Renal Transplantation for HIV/HCV Co-infected Patients Solid Organ Transplantation and People With HIV: Ethics and Policy Conference David Oldach & Robert.
Differences between radiology and histopathology: Are we judging correctly? Simona Onali 1, Emmanuel Tsochatzis 1, James O’Beirne 1, Aileen Marshall 1,
Liver fibrosis regression after anti HCV therapy and the rate of death, liver-related death, liver- related complications, and hospital.
Biomedical Technology Unit Treatment for heart disease Heart-lung machine Treatment for cancer Treatment for diabetes Bone marrow transplants.
Living Donor Liver Transplantation in PSC Patients Giuliano Testa, MD, FACS, MBA Surgical Director, Living Donor Liver Transplantation Baylor University.
Proposal to Delay the HCC Exception Score Assignment (Resolution 9) Liver and Intestine Committee David Mulligan, Chair November 12 and 13, 2014.
Hepatitis C+ Recipients: Considerations for Exclusion Emily A. Blumberg, M.D.
Ethics and Policy Conference Day One Summary. Goals of the Meeting Educate people about the status of various protocol decisions Define areas where we.
Transplantation in HIV Michelle Roland, MD Assistant Professor of Medicine UCSF Positive Health Program at SFGH.
SOLAR-2 LDV/SOF + RBV Randomisation of the 7 groups 1 : 1 Open-label SOLAR-2 Study: LDV/SOF + RBV in decompensated and post-liver transplant with genotype.
SMV + DCV + SOF Open label Chronic HCV infection Genotype 1 or 4 Treatment-naïve or pre-treated with PEG-IFN ± RBV Portal hypertension or liver decompensation.
ORGAN TRANSPLANTATION: PERSONS WITH DETECTABLE HIV VIRAL LOAD Margaret Ragni, MD University of Pittsburgh.
Transplantation in HIV+ Recipients Ron Shapiro, M.D. THOMAS E. STARZL TRANSPLANTATION INSTITUTE UNIVERSITY OF PITTSBURGH.
Open-label W24 ≥ 18 years Chronic HCV infection All genotypes HCV RNA ≥ 10,000 IU/ml Liver transplantation months earlier Child Pugh ≤ 7 and MELD.
Luís Mendão European AIDS Treatment Group, GAT/H-CAB ELPA Symposium Compassionate use programs for hepatitis C patients with advanced disease Saturday,
Trends in Treatment of Recurrent Hepatitis C After Liver Transplantation Kate Forgan-Smith KA Stuart 1,4, C Tallis 1,4 GA Macdonald 1,3,4, J Fawcett 2,3.
Date of download: 6/1/2016 From: Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons Ann Intern Med. 2016;164(2): doi: /M
Liver transplantation for HCV infection R3 양 인 호 /Prof 김 병 호.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
Setting the Scene. Non A, non B Hepatitis  Early 1970’s recognised that 2/3 of post transfusional hepatitis were –ve for both Hep A & Hep B Non Hep A.
심 재 준심 재 준 Am J Gastroenterol 2007;102:
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Date of download: 9/17/2016 From: The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions Ann Intern Med. 2014;161(3):
Adefovir Suppresses HBV DNA Levels in Lamivudine-Resistant HIV/HBV Patients Slideset on: Benhamou Y, Thibault V, Vig P, et al. Safety and efficacy of adefovir.
Hepatitis B virus infection in renal transplant recipients
Treatment of HBV/HCV Coinfection
Acute Liver Failure Anand Annamalai.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
Value in Health Regional Issues
Design Randomisation 1 : 1 Open-label W16 W24 > 18 years
Interactive Workshop.
Volume 150, Issue 2, Pages e6 (February 2016)
HCV & liver transplantation
Volume 18, Issue 1, Pages (January 2016)
Liver Transplantation: 50 years
The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America Present HCV Guidance: Recommendations for Testing,
The Aging Liver in the Aging HIV and HCV Patients
Figure 2 A stage-based approach to the treatment of NAFLD
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Evaluation of the Patient With HCV Infection
Changes to HCC Criteria for Auto Approval
Value in Health Regional Issues
Care of the Treatment-naive Patient With HCV/HIV Coinfection
Primary Biliary Cholangitis
Roberts Brown, Jean C. Emond  Gastroenterology 
Clinical outcome after SVR: ANRS CO22 HEPATHER
Correction Journal of the American College of Surgeons
Advances in the Treatment of HCV Genotype 3 and HIV/HCV Coinfection
Proposal to Delay the HCC Exception Score Assignment
Volume 140, Issue 7, Pages (June 2011)
Deceased-Donor Split-Liver Transplantation in Adult Recipients: Is the Learning Curve Over?  Ryan P. Cauley, MD, MPH, Khashayar Vakili, MD, FACS, Nora.
PRESENTER: Quynh vu, pgy-2
Liver Transplantation for Hepatocellular Carcinoma
Core Competency 1: Epidemiologic Background of HIV/HCV Co-infection in the United States Lesson 2: Morbidity and Mortality in HCV Co-infected People Living.
The outcome of the initial assessment of hepatocellular carcinoma (HCC) by a multidisciplinary meeting (MDM) with respect to treatment categorised as resection,
Volume 135, Issue 5, Pages (November 2008)
NAFLD and NASH in Europe and Canada
Prognostic effect of complete pathologic response following TACE on HCC patients undergoing liver resection or transplantation Prognostic effect of complete.
Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation? Rahim MN et al., Liver Transplantation 2019 Jun; 25(6): Journal Club.
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Outline

Statistics

Major Causes of Liver Disease in HIV

HIV/HCV Coinfection Decreases Survival

Drug-Induced Hepatoxicity

Hepatocellular carcinoma

Liver Transplantation and HIV

Liver Transplant Trends In HIV+

Liver Transplant Criteria

Model for End Stage Liver Disease (MELD)

Is MELD equivalent in HIV+ vs. HIV-?

Pretransplant Mortality in HIV+ Transplant Candidates

Post-Transplant Issues

Post-Transplant Survival

HCV/HIV Post-LT Outcomes

Survival of HIV/HCV post-OLT

Progression of Fibrosis Post-Transplant

Increased Fibrosis Progression Rate

Treatment of HCV/HIV post-LT

HIV/HBV Post-LT Outcomes

HIV/HBV Survival Post-LT

HIV/HBV

HIV/HCC and OLT

Infection Post LT

Predictive Factors Associated with Severe Infection

HIV and Prothrombotic State

Rejection and HIV post-LT

Benefits of Immunosuppression?

Management of HIV post-LT

Future directions

Summary